Zurich Cantonal Bank’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.65M Buy
45,568
+5,566
+14% +$302K 0.01% 894
2025
Q4
$1.85M Buy
40,002
+1,253
+3% +$56K 0.01% 989
2025
Q3
$1.4M Hold
38,749
﹤0.01% 1104
2025
Q2
$1.26M Buy
38,749
+9,114
+31% +$299K ﹤0.01% 1112
2025
Q1
$1.12M Buy
29,635
+436
+1% +$34.9K ﹤0.01% 1099
2024
Q4
$2.39M Buy
29,199
+7,888
+37% +$783K 0.01% 783
2024
Q3
$2.44M Buy
21,311
+826
+4% +$74.4K 0.01% 740
2024
Q2
$1.55M Buy
20,485
+2,139
+12% +$146K 0.01% 842
2024
Q1
$1.25M Buy
18,346
+1,193
+7% +$82.6K ﹤0.01% 957
2023
Q4
$1.08M Buy
17,153
+6,229
+57% +$324K ﹤0.01% 1028
2023
Q3
$557K Buy
10,924
+1,233
+13% +$60.8K ﹤0.01% 1327
2023
Q2
$484K Buy
9,691
+1,479
+18% +$70.1K ﹤0.01% 1371
2023
Q1
$308K Buy
8,212
+798
+11% +$33.9K ﹤0.01% 1614
2022
Q4
$356K Buy
7,414
+538
+8% +$21.1K ﹤0.01% 1458
2022
Q3
$165K Buy
6,876
+2,012
+41% +$51K ﹤0.01% 1865
2022
Q2
$106K Sell
4,864
-102
-2% -$2.36K ﹤0.01% 2195
2022
Q1
$120K Buy
+4,966
New +$108K ﹤0.01% 2201

Other funds holding PCVX